402 related articles for article (PubMed ID: 16514606)
1. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.
Zcharia E; Metzger S; Chajek-Shaul T; Aingorn H; Elkin M; Friedmann Y; Weinstein T; Li JP; Lindahl U; Vlodavsky I
FASEB J; 2004 Feb; 18(2):252-63. PubMed ID: 14769819
[TBL] [Abstract][Full Text] [Related]
3. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
4. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice.
Nunes AF; Liz MA; Franquinho F; Teixeira L; Sousa V; Chenu C; Lamghari M; Sousa MM
FEBS J; 2010 Jan; 277(1):263-75. PubMed ID: 19954489
[TBL] [Abstract][Full Text] [Related]
6. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
7. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
8. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.
Kalajzic I; Kalajzic Z; Kaliterna M; Gronowicz G; Clark SH; Lichtler AC; Rowe D
J Bone Miner Res; 2002 Jan; 17(1):15-25. PubMed ID: 11771662
[TBL] [Abstract][Full Text] [Related]
9. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
10. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of heparan sulfate derived from murine hemopoietic stromal cell lines: a bone marrow-derived cell line S17 and a fetal liver-derived cell line AFT024.
Arcanjo K; Belo G; Folco C; Werneck CC; Borojevic R; Silva LC
J Cell Biochem; 2002; 87(2):160-72. PubMed ID: 12244569
[TBL] [Abstract][Full Text] [Related]
14. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
17. Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype.
Yang J; Murthy S; Winata T; Werner S; Abe M; Prahalad AK; Hock JM
Biochem Biophys Res Commun; 2006 May; 344(1):346-52. PubMed ID: 16600186
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
[TBL] [Abstract][Full Text] [Related]
19. Regulation of osteoblast differentiation by slit2 in osteoblastic cells.
Sun H; Dai K; Tang T; Zhang X
Cells Tissues Organs; 2009; 190(2):69-80. PubMed ID: 19033678
[TBL] [Abstract][Full Text] [Related]
20. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
